Eribulin mesylate exerts antitumor effects via CD103
Eribulin mesylate (ERB) is a synthetic analog of halichondrin B, inhibiting tumor cell growth by disrupting microtubule function. Recently, anticancer drugs have been shown to not only act directly on tumor cells but also to exert antitumor effects by modifying the tumor environment. Although ERB ha...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis Group
2023-12-01
|
| Seri Bilgileri: | OncoImmunology |
| Konular: | |
| Online Erişim: | https://www.tandfonline.com/doi/10.1080/2162402X.2023.2218782 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|